Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Long-Term Debt Repayments (2020 - 2021)

Caribou Biosciences (CRBU) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $119000.0 as the latest value for Q1 2021.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $119000.0 in Q1 2021 year-over-year; TTM through Dec 2021 was $119000.0, a N/A change, with the full-year FY2021 number at $119000.0, up 5.31% from a year prior.
  • Long-Term Debt Repayments was $119000.0 for Q1 2021 at Caribou Biosciences, up from $32000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $119000.0 in Q1 2021 to a low of $31000.0 in Q3 2020.